Michael Berelowitz, Director at ORAMED PHARMACEUTICALS INC. (ORMP), sold 1,300 shares at $8.70 ($11K) on 2015-12-07, disclosed to the SEC on 2015-12-09.
Open-market sale of $11k ORMP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.70 | 539 | $5K | 41.5% |
| 2 | $8.70 | 761 | $7K | 58.5% |
| Total | $8.70 avg | 1,300 | $11K | 100% |
| Filing → |
| ORMP | SELL | 2014-04-02 | $99K | — | Filing → |